Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of Ferric Carboxymaltose in NDD-CKD Anemia
NCT00317226Phase 3Completed
- Sponsor
- American Regent, Inc.
- Start
- Jun 2005
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ferric carboxymaltose in anemia, sponsored by American Regent, Inc.. Started Jun 2005; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00317226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317226.